{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:14:07Z","timestamp":1696230847913},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.transproceed.2008.09.052","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T10:56:46Z","timestamp":1227005806000},"page":"3063-3064","source":"Crossref","is-referenced-by-count":2,"title":["Utility of Oral Valganciclovir for Cytomegalovirus Prophylaxis: Does It Improve Treatment Compliance?"],"prefix":"10.1016","volume":"40","author":[{"given":"J.A.","family":"Moro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mart\u00ednez-Dolz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Blanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"S\u00e1nchez-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2008.09.052_bib1","series-title":"Transplant infections","first-page":"298","article-title":"Cytomegalovirus infection after solid organ transplantation","author":"Paya","year":"2003"},{"key":"10.1016\/j.transproceed.2008.09.052_bib2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1053-2498(01)00399-0","article-title":"Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial","volume":"21","author":"Egan","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2008.09.052_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF03217708","article-title":"Is it possible to reduce CMV-infections after heart transplantation with a three-month antiviral prophylaxis?","volume":"116","author":"Antretter","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.transproceed.2008.09.052_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1053-2498(03)00200-6","article-title":"Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients","volume":"23","author":"Vrtovec","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2008.09.052_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2007-1024260","article-title":"Cytomegalovirus infection after heart transplantation","volume":"125","author":"Antretter","year":"2000","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.transproceed.2008.09.052_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.healun.2003.08.034","article-title":"Pre-emptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation","volume":"23","author":"Devyatko","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2008.09.052_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00007890-199803150-00026","article-title":"Preemptive treatment for the prevention of cytomegalovirus disease in lung and heart transplant recipients","volume":"65","author":"Egan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2008.09.052_bib8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508013432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134508013432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T09:21:50Z","timestamp":1545643310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134508013432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0041134508013432"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2008.09.052","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}